Wirksamkeit des neuen Phosphodiesterase 4-Inhibitors Roflumilast bei Rauchern und Exrauchern mit COPD

Autor: A Kroker, J Eller, A Linnhof, H Rusch, NA Hanania, H Worth

Publikováno v: Pneumologie. 66

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::238b1cfa7534d971771734f9aa948938
https://doi.org/10.1055/s-0032-1302623

Endobronchial Tuberculosis

Autor: SS Dhillon, NA Hanania

Publikováno v: Tuberculosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca143d854a2e0005fa9e13175e7d03ef
https://doi.org/10.5005/jp/books/10992_16

Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).

Autor: Bhatt SP; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: sbhatt@uabmc.edu., Rabe KF; LungenClinic Grosshansdorf and Christian Albrechts University of Kiel, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany. Electronic address: k.f.rabe@lungenclinic.de., Hanania NA; Department of Medicine, Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA., Vogelmeier CF; Department of Medicine, Pulmonary, and Critical Care Medicine, University of Marburg, German Center for Lung Research (DZL), Marburg, Germany., Bafadhel M; King's Centre for Lung Health, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK., Christenson SA; Division of Pulmonary, Critical Care, Allergy, & Sleep Medicine, University of California San Francisco, San Francisco, CA, USA., Papi A; Department of Cardiorespiratory Medicine, Respiratory Unit, University of Ferrara, Ferrara, Italy., Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK., Laws E; Sanofi, Bridgewater, NJ, USA., Dakin P; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Maloney J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Lu X; Sanofi, Bridgewater, NJ, USA., Bauer D; Sanofi, Bridgewater, NJ, USA., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Robinson LB; Sanofi, Cambridge, MA, USA., Abdulai RM; Sanofi, Cambridge, MA, USA.

Publikováno v: Respiratory medicine [Respir Med] 2024 Oct 29, pp. 107846. Date of Electronic Publication: 2024 Oct 29.

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences.

Autor: Cazzola M; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. mario.cazzola@uniroma2.it., Page CP; Institute of Pharmaceutical Science, King's College London, London, UK., Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA., Calzetta L; Department of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy., Matera MG; Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Rogliani P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.

Publikováno v: Drugs [Drugs] 2024 Oct; Vol. 84 (10), pp. 1251-1273. Date of Electronic Publication: 2024 Sep 26.

Dynamic and prognostic proteomic associations with FEV 1 decline in chronic obstructive pulmonary disease.

Autor: Ruvuna L; Pulmonary Sciences and Critical Care Medicine University of Colorado Denver, Colorado.; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, United States., Hijazi K; Novartis Institute of Biomedical Research, Cambridge, MA, United States., Guzman DE; Columbia University Irving Medical Center, New York Presbyterian, New York, NY, United States., Guo C; National Jewish Health, Denver, CO, United States., Loureiro J; Novartis Institute of Biomedical Research, Cambridge, MA, United States., Khokhlovich E; Novartis Institute of Biomedical Research, Cambridge, MA, United States., Morris M; Novartis Institute of Biomedical Research, Cambridge, MA, United States., Obeidat M; Novartis Institute of Biomedical Research, Cambridge, MA, United States., Pratte KA; National Jewish Health, Denver, CO, United States., DiLillo KM; Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States., Sharma S; Pulmonary Sciences and Critical Care Medicine University of Colorado Denver, Colorado., Kechris K; Department of Biostatics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Anzueto A; University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, Texas., Barjaktarevic I; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Bleecker ER; Mayo Clinic School of Medicine - Scottsdale Campus Scottsdale, AZ, US., Casaburi R; Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles Medical Center, Torrance, California., Comellas A; Carver College of Medicine, University of Iowa, Iowa City, Iowa., Cooper CB; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., DeMeo DL; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Foreman M; Pulmonary and Critical Care Medicine Division, Morehouse School of Medicine, Atlanta, GA., Flenaugh EL; Pulmonary and Critical Care Medicine Division, Morehouse School of Medicine, Atlanta, GA., Han MK; Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan., Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX., Hersh CP; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Krishnan JA; Breathe Chicago Center, Division of Pulmonary and Critical Care Medicine, University of Illinois at Chicago College of Medicine, Chicago, Illinois., Labaki WW; Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan., Martinez FJ; Department of Medicine, Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York., O'Neal WK; Marsico Lung Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Paine R 3rd; Division of Respiratory, Critical Care and Occupational Medicine, University of Utah, Salt Lake City, Utah, United States., Peters SP; Department of Internal Medicine, Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina., Woodruff PG; Division of Pulmonary Critical Care, Allergy, and Sleep Medicine, University of California San Francisco, San Francisco, California, United States., Wells JM; Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama., Wendt CH; Minneapolis VA Health Care System, Minneapolis, Minnesota.; University of Minnesota, Minneapolis, Minnesota Medical Service, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, United States., Arnold KB; Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States., Barr RG; Columbia University Irving Medical Center, New York Presbyterian, New York, NY, United States., Curtis JL; Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan.; Medical Service, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, United States., Ngo D; Novartis Institute of Biomedical Research, Cambridge, MA, United States., Bowler RP; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, United States.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.